United States · FDA National Drug Code directory
Rivaroxaban
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-981_eafdf7d8-5014-31c8-daa1-09fc017f5018
- Product NDC
- 43598-981
- Form
- TABLET
- Composition / generic term
- Rivaroxaban
- Labeler
- Dr.Reddy's Laboratories, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250514
- Source listing expiry
- 20271231
Source-listed ingredients
- RIVAROXABAN — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET in 1 BOTTLE (43598-981-18) · 43598-981-18
- 60 TABLET in 1 BOTTLE (43598-981-60) · 43598-981-60
- 10 BLISTER PACK in 1 CARTON (43598-981-78) / 10 TABLET in 1 BLISTER PACK (43598-981-79) · 43598-981-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →